Blood-Based Biomarkers for Alzheimer's Disease Identified

In the first study, researchers identified a panel of plasma biomarker candidates, including cortisol and pancreatic polypeptide (PP), which distinguishes individuals with AD from cognitively healthy control patients.
A second study confirmed CSF studies reporting increased levels, not only of PP, but also of N-terminal protein beta-type brain natriuretic peptide (NT-proBNP), in patients with AD and mild cognitive impairment (MCI).
Both studies appeared in the Archives of Neurology.

1 comment:

toby magmire said...

Administration of chronic wellness problems like high blood strain, diabetes, thyroid problems, and heart disorder is a significant part of most major care physician's perform.